Hiroki Anezaki

Hiroki Anezaki

Auto-generated profile, based on publicly available information

Hiroki Anezaki

Department of Anaesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2025 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
HAHiroki Anezaki
Hiroki Anezaki
YAYoshitaka Aoki
Yoshitaka Aoki
HKHiromi Kato
Hiromi Kato
MNMikio Nakajima
Mikio Nakajima
RKRichard H. Kaszynski
Richard H. Kaszynski
YNYoshiki Nakajima
Yoshiki Nakajima

6 March 2022 in Cureus
Verified
Journal Article
Open access
SSShin Suzuki
Shin Suzuki
YAYoshitaka Aoki
Yoshitaka Aoki
HAHiroki Anezaki
Hiroki Anezaki
CWChiharu Wakuda
Chiharu Wakuda
SOShinji Oshima
Shinji Oshima
YNYoshiki Nakajima
Yoshiki Nakajima
We hypothesized that the nephroprotective and diuretic effects of carperitide are effective in patients with pulmonary hypertension. We examined the presence of preoperative pulmonary hypertension and the effects of carperitide. In this retrospective cohort study, we included patients aged 20 years or older who received carperitide during cardiovascular surgery and were admitted to the postoperative intensive care unit. We used hospital data from March 2019 to September 2021. The outcomes were the incidence of acute kidney injury, the number of patients using renal replacement therapy in the intensive care unit, urine volume in the first 24 hours after surgery, and the difference in serum creatinine concentrations between before and after surgery. After adjusting for confounding factors by multivariate analysis, we compared the difference in outcomes with and without preoperative pulmonary hypertension (systolic pulmonary artery pressure ≥36 mmHg). The study included 244 patients, with 72 (29.5%) in the pulmonary hypertension group and 172 (70.5%) in the control group. Acute kidney injury occurred in eight (11.1%) patients in the pulmonary hypertension group and in 18 (10.5%) patients in the control group, with no significant difference by logistic regression analysis (odds ratio 1.40, 95% confidence interval 0.54-3.62, p=0.49). Additionally, the use of renal replacement therapy, urine volume at 24 hours postoperatively, and the difference in serum creatinine concentrations were not different between the two groups. Our results suggest that the effect of carperitide during cardiovascular surgery is not affected by the presence or absence of pulmonary hypertension.

21 June 2026 in Renal Replacement Therapy
Verified
Journal Article
Open access
HAHiroki Anezaki
Hiroki Anezaki
SKShingo Kawashima
Shingo Kawashima
AKAtsushi Kobayashi
Atsushi Kobayashi
WKWakana Kawashima
Wakana Kawashima
MOMasahiko Ohashi
Masahiko Ohashi
HKHiroyuki Kinoshita
Hiroyuki Kinoshita
Background: Hypermagnesemia in a surgical patient potentially causes arrhythmias, whereas it rarely induces devastating outcomes, including cardiac arrest, in the perioperative period. Here, we present a woman who underwent an emergent colostomy owing to impending bowel rupture, immediately after cardiac arrest caused by severe hypermagnesemia due to the magnesium-containing laxative overdose prescribed for chronic constipation and fecal obstruction. Case presentation: An 81-year-old woman with chronic constipation developed fecal obstruction despite a large volume of magnesium-containing laxatives to relieve her constipation. She visited our emergency department because she felt severe abdominal pain continuously. Shortly after she arrived at the emergency department, she developed abrupt cardiac arrest, and she was successfully resuscitated by ordinary treatments, including 1 mg of intravenous (IV) adrenaline. Her laboratory test on arrival revealed a serum magnesium level of 18.3 mg/dL. Our surgeons diagnosed her condition as impending bowel rupture, and therefore, they proceeded with an emergent colostomy without preceding renal replacement therapy. We implemented the following procedures to decrease her serum magnesium level: an intravenous 425 mg calcium gluconate, 20 mg of a loop diuretic furosemide, and a large-volume crystalloid infusion, resulting in her serum magnesium level of 12.8 mg/dL during her surgical procedure. The postoperative use of two hemodialysis session led to a normal range of serum magnesium (2.8 mg/dL). The patient’s postoperative course was uneventful, and she was discharged on postoperative day 37. Conclusions: The current case report documented that magnesium-containing laxative overdose causes severe hypermagnesemia, resulting in abrupt cardiac arrest, and that a specific emergency surgical procedure is feasible with efforts to decrease the serum magnesium level. However, we argue that implementation of renal replacement therapy, including continuous hemodiafiltration, in addition to surgical intervention, might be one of the best management strategies in a patient with severe hypermagnesemia in combination with an impending surgical problem.

20 October 2026 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
HAHiroki Anezaki
Hiroki Anezaki
SMSoichiro Mimuro
Soichiro Mimuro
NWNaoki Washiyama
Naoki Washiyama
YTYuki Takeuchi
Yuki Takeuchi
KOKazuma Okamoto
Kazuma Okamoto
YNYoshiki Nakajima
Yoshiki Nakajima